Cardiac sarcoidosis: An algorithmic approach to diagnosis and treatment of the "Great Mimicker"

Irena Kuzma1, Kristen R Mathias2, Jana Lovell3

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Insights

Cardiac sarcoidosis (CS) involves granulomas in the heart, causing arrhythmias and cardiomyopathy. Differentiating CS from similar cardiac conditions, especially rheumatologic mimics, is vital for effective patient management and preventing mortality.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pathology

Background:

  • Cardiac sarcoidosis (CS) is characterized by myocardial infiltration of non-necrotizing granulomas.
  • CS presents with diverse clinical manifestations, including life-threatening arrhythmias and cardiomyopathy.
  • Accurate diagnosis of CS is essential to distinguish it from mimics and prevent severe patient outcomes.

Purpose of the Study:

  • To review diagnostic strategies for cardiac sarcoidosis.
  • To outline methods for differentiating CS from clinically similar cardiac pathologies, particularly rheumatologic conditions.
  • To discuss current approaches to the management and treatment of CS.

Main Methods:

  • Literature review focusing on diagnostic criteria and differential diagnoses for CS.
  • Comparative analysis of CS with other cardiac conditions, emphasizing rheumatologic differentials.
  • Synthesis of information on CS management and therapeutic strategies.

Main Results:

  • CS diagnosis requires careful consideration of clinical presentation, imaging, and biopsy findings.
  • Distinguishing CS from conditions like lupus carditis or rheumatoid heart disease is critical.
  • Multidisciplinary management involving cardiology and rheumatology is often necessary.

Conclusions:

  • Early and accurate diagnosis of CS is paramount for timely intervention.
  • Differential diagnosis is key, especially when considering rheumatologic conditions with cardiac involvement.
  • Effective management strategies improve patient prognosis and reduce mortality associated with CS.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...